Rest your eyes or use your commute time to learn. Listen to our experts discuss the hot topics that you need to track. And get a glimpse into the personalities behind the smiles.
For Malnutrition Awareness WeekTM, Avalere will be releasing a series of podcasts focused on new tools developed by the Malnutrition Quality Improvement Initiative (MQii)—a collaboration of the Academy of Nutrition and Dietetics, Avalere Health, and other organizations dedicated to improving nutrition care. Listen to episode 1 featuring Dr. Alison Steiber, chief science officer at the Academy of Nutrition and Dietetics, and Dr. Beverly Hernandez, the director of clinical nutrition at Tampa General Hospital.
In our final bundled payment podcast, Avalere's Adam Borden discusses how the potential updates may impact device manufacturers.
In the third podcast in our bundled payment series, Avalere's Mary Ann Clark discusses how the potential updates may impact device manufacturers.
In episode 2 of our bundled payment podcast series, Avalere's Sally Rodriguez shares how the potential updates may impact post-acute care providers.
For the month of August, Avalere will cover what the new proposed changes to existing bundled payment programs could mean for the healthcare industry. In an exclusive podcast series, experts will discuss what the new bundles include and where to go from here. Kicking off this series is Fred Bentley from our Center for Payment and Delivery Innovation.
Between now and November, Avalere will to bring election content, including podcasts to the public dialogue. Our experts provide a quick glimpse into the role healthcare will play in the 2016 elections and hot topics you can expect to hear about on the campaign trail
Listen as our expert, Jay Jackson, discusses recent final guidance issued by the FDA on compassionate use.
Between now and November, Avalere will to bring election content—including podcasts—to the public dialogue. Our experts provide a glimpse into the role healthcare will play in the 2016 elections and hot topics you can expect to hear about on the campaign trail.
Listen in as Avalere's Biruk Bekele talks about a new model Avalere has developed to help life sciences companies more effectively target ACOs and customize their value propositions in the diabetes space based on ACO performance. The number of ACOs has grown rapidly in the past few years, reflecting the Department of Health and Human Services’ push to move 50% of Medicare spending to value-based payment models by 2018.
Our experts share the lessons that we’ve learned from our extensive experience with the Bundled Payments for Care Improvement Initiative. The Bundled Payments for Care Improvement demonstration is a voluntary program sponsored by CMMI in which hospitals, physician group practices, and post-acute care providers accept clinical and financial risk for patients over specified episode time frames post-hospital discharge.
HHS released a proposed rule to MACRA which implements two pathways: Merit-Based Incentive Payment System and Advanced Alternative Payment Models. In this podcast, Avalere's Angel Valladares discusses the four performance categories.
In order to better coordinate care across the care continuum, CMS is allowing hospitals to establish “CJR Collaborators” or other providers that share risk with the participating hospital. Listen as Fred Bentley and Erica Breese discuss the details.
The Medicare Access and CHIP Reauthorization Act (MACRA) passed last spring is transforming physician payment and standardizing requirements for APMs. Listen as Adam Borden and Jared Alves cover Advanced APMs, incentives CMS offers for providers to participate in APM, and the exclusion of specific tracks.
Are bundled payments fundamentally changing the way care is provided? Listen in as Fred Bentley, Avalere Center & Payment Delivery Innovation, explains how bundled payment models are spurring clinical innovation and the creation of cross-continuum partnerships.
In our patient engagement series, hear Alex Goolsby discuss opportunities for provider organizations, health plans, patient advocacy groups, and drug and device manufacturers to engage patients through education and collaboration to improve healthcare.
In recent years, stakeholders have increasingly become aware of the potential opportunities surrounding incorporation of the patient perspective into early stages of drug development. Listen to Debleena Sengupta discuss how patient input is evaluated and incorporated into the FDA's decision-making process.
To what extent do patients currently have access to their own data in their providers’ electronic health records, and what does the future hold for consumer access to their digital health data? Listen to Avalere's Josh Seidman share how far we’ve come with providing patients access to their health data, where there is still room for improvement, and what patients can expect to see in the future.
While Medicare Access and CHIP Reauthorization Act or MACRA seeks to stabilize Medicare and assure physicians a predictable stream of revenue given a schedule of expected physician payment updates, how can providers leverage MACRA to improve quality of care? Listen in as Kristi Mitchell suggests how providers can use MACRA as a springboard to develop and implement relevant quality measures to close the current measurement gaps across disease conditions and care settings.
The ACA is built on a foundation of improving the quality of care for all patients and includes a number of provisions to help consumers make decisions about where to receive their care as well as how to increase the transparency of services through value-based purchasing efforts and private sector programs. Listen in as Nelly Ganesan discusses the trend of using value-based systems in quality reporting programs which will require physicians to focus on outcomes versus processes.
When life sciences companies consider whether to allow compassionate use—access to unapproved investigational treatments outside of clinical trials—there are no easy answers. Brenda Huneycutt gleans insight from Arthur Caplan, PhD, and Alison Bateman-House, PhD, from the New York University Langone Medical Center Division of Medical Ethics on some of the many questions that life sciences companies should ask themselves before implementing a compassionate use policy.